Author Correction:Autophagy inhibitors increase the susceptibility of KRAS-mutant human colorectal cancer cells to a combined treatment of 2-deoxy-D-glucose and lovastatin  

作　　者：Xiao-ming Huang Jia-jun Huang Jing-jing Du Na Zhang Ze Long You Yang Fang-fang Zhong Bo-wen Zheng Yun-fu Shen Zhe Huang Xiang Qin Jun-he Chen Qian-yu Lin Wan-jun Lin Wen-zhe Ma 

机构地区：[1]State Key Laboratory of Quality Research in Chinese Medicine,Macao University of Science and Technology,Macao,China

出　　处：《Acta Pharmacologica Sinica》2022年第7期1881-1881,共1页中国药理学报（英文版）

摘　　要：The authors apologize that in Fig.5d,the western blotting bands of HCT116 cells treated with 2DG(5 mM)and different concentrations of lovastatin were the same as cells treated with lovastatin(10μM)and different concentrations of 2DG,which was misplaced inadvertently.The correct figure is reproduced and presented.The conclusions are not affected by this correction.We sincerely apologize for our mistakes and any inconvenience this might have caused.

关 键 词：HCT116 LOVASTATIN KRAS 

分 类 号：R96-5[医药卫生—药理学] G23[医药卫生—药学]